Squamous cell carcinoma (SCC) antigen levels were studied in 34 patients with primary (N = 27) or recurrent (N = 7) SCC of the vulva. In primary disease, the SCC antigen level was greater than 2.5 ng/ml in only four patients ( 15 %) . Elevated antigen levels ranged from 2.7-1 8 .O ng/ml . All of the
Squamous cell carcinoma antigen serum levels as prognostic parameter in patients with early stage vulvar cancer
โ Scribed by Lukas A. Hefler; Gerhard Sliutz; Sepp Leodolter; Paul Speiser; Elmar Joura; Alexander Reinthaller; Petra Kohlberger
- Book ID
- 113959903
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 127 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0090-8258
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Our aim was to evaluate whether serum concentrations of squamous cell carcinoma antigen (SCC-Ag) are an independent prognostic factor in patients with vulvar cancer. We measured SCC-Ag in pretreatment serum samples of 55 patients with squamous cell vulvar cancer, 30 patients with vulvar intraepithel
Our aim was to evaluate the clinical usefulness of serum concentrations of squamous-cell carcinoma antigen (SCC-Ag) and tissue polypeptide antigen (TPA) in the follow-up of patients with vulvar cancer. We measured SCC-Ag and TPA in 480 serum samples of 82 patients with squamous-cell vulvar cancer. R